Acute DVT ‐ antiplatelet agents plus BMP vs BMP alone
Adverse events · people requiring treatment for acute DVT
It is very uncertain whether acute DVT ‐ antiplatelet agents plus BMP changes adverse events compared with BMP alone (very low certainty).
1 finding from 1 review
- Antiplatelet agents for the treatment of deep venous thrombosis 2022 · Cochrane Headline outcomes onlyRR 2.88 [1.06, 7.8]1 study · 500 participantsVery low